Shodeinde Coker

WORK HISTORY

EDUCATION

ABOUT SHODEINDE COKER

Self-directed, driven physician and clinical pharmacologist with a comprehensive background in medical instruction and clinical research, including early phase clinical trial development and oversight. Known as an innovative thinker with strong protocol administration skills, oncology and hematological disease acumen. A highly organized and adept medical adviser who excels at guiding teams through complex experimental projects and spearheading innovative pharmacological investigations. Demonstrated success advising, developing and seamlessly executing experimental research published in medical journals. Board certified in General Internal Medicine, Medical Oncology, Hematology and Clinical Pharmacology.Accomplishments:• Sub-investigator and co-investigator on multiple industry-sponsored and investigator initiated early phase clinical trials involving Lapatinib, AMG-386, Linifanib, Vismodegib, Sorafenib and Ixazomib.• Research investigator, pilot grant recipient and valued oncology research clinician involved in the targeting of the aryl hydrocarbon receptor role in obesity and cancer, a drug interaction study of a novel Wee1 inhibitor, an NTRK inhibitor basket study and a Phase IA/IIB study of a novel connective tissue growth factor antibody.Expertise:Clinical Research, Medical Education, Hospitals, Global Health, Healthcare, ACLS, Clinical Research, EMR, Epidemiology, Clinical Trial Analysis, Oncology, Research Funding, Clinical Pharmacology, Pharmacology, Research Ethics, Protocol Writing, Electronic Medical Record (EMR), Patient Education, Pharmaceutical Research, Publications, Regulatory Compliance, Drug Interactions, Quality Patient Care, Cancer Treatment, Hematology, Clinical Study Design, Good Clinical Practice (GCP), Educational Leadership, Medical Research, Design of Experiments, Experimental Design, Internal Compliance, SOP Development, Industry Research, Drug Development, Pharmaceutical Industry, Surgery